With over $2.9B assets under management, Frazier Healthcare Partners is a leading provider of growth capital to healthcare companies, focusing on Life Sciences and Growth Buyout investments.

Life Sciences

Acquired by AstraZeneca in 2016
IPO in 2015 (NASDAQ: COLL)
Acquired by Valeant Pharmaceuticals in 2014
Acquired by The Medicines Company in 2013

Growth Buyout

Acquired by The Partners Group

News

Frazier Healthcare Partners

James Topper Included in 2016 Midas List

Frazier Healthcare Partners

Providence Service Corporation and Frazier Healthcare Partners Announce Strategic Partnership in Matrix Medical Network

PCI

Pharma Packager PCI Sells for More Than $1 Billion

Tobira Therapeutics

Allergan to Acquire Tobira Therapeutics